Oncology

Dr. Swasthik Upadhya P

MBBS, MD (Gen Med), DM (Med Onco), ECMO
Medical Oncologist · AIIMS New Delhi

KMC Reg. 117203 | DMC Reg. 101197

Publications

AIIMS

DM Training, New Delhi

State 1st

MD Gold Medallist

Published Papers

ESMO

Certified (2024)

Academic Excellence — Gold Medallist

Gold Medallist

🥇

Dr. TMA Pai Gold Medal — Best Outgoing Student

KMC, Mangalore (MAHE) · MBBS 2011 Batch

🥇

State 1st Rank & Gold Medal — MD General Medicine

JJM Medical College, Davangere (RGUHS, Bangalore) · 2020

🥇

Gold Medal — Microbiology

KMC, Mangalore (MAHE)

🥇

Gold Medal — Pharmacology

KMC, Mangalore (MAHE)

🥇

Gold Medal — Ophthalmology

KMC, Mangalore (MAHE)

🏆

Distinction — DM Medical Oncology

AIIMS, New Delhi · 2024

About

The specialist
behind your care.

Dr. Swasthik Upadhya P is a highly accomplished Medical Oncologist with a DM from AIIMS, New Delhi — India's premier medical institution. He brings expertise in managing both solid and hematological malignancies, with special proficiency in stem cell transplant and CAR T cell therapy. A passionate researcher with multiple peer-reviewed publications, Dr. Swasthik is also a decorated gold medallist — holding the State 1st Rank in MD General Medicine and the Dr. TMA Pai Gold Medal for best outgoing MBBS student from KMC Mangalore.

Medical Oncology Haematological Malignancies Stem Cell Transplant CAR T Cell Therapy Immunotherapy Targeted Therapy Breast Cancer Gynecologic Oncology Thoracic Oncology Head & Neck Cancer Lymphomas Clinical Trials

Areas of Expertise

Clinical
specialisations.

Solid Tumour Oncology

Expert management of Gynecologic, Thoracic, Head & Neck and Breast cancers with evidence-based chemotherapy, targeted therapy and immunotherapy protocols.

Haematological Malignancies

Comprehensive care for Lymphomas, Leukaemias and Myeloma including bone marrow assessment, PICC/Hickman line procedures and chemotherapy administration.

Stem Cell Transplant & CAR T Cell Therapy

Advanced AIIMS-trained expertise in stem cell transplantation and CAR T cell therapy — among the most specialised treatments in modern oncology.

Immunotherapy & Targeted Therapy

Expert use of checkpoint inhibitors, biosimilars and molecular-targeted agents across a broad range of cancer diagnoses.

Phase I–III Clinical Trials

Experienced co-investigator on international Phase III trials (AVANZAR, EVOLVE) with skills in data analysis and statistical interpretation.

Procedural Oncology

Proficient in bone marrow aspiration and biopsy, lumbar puncture, central venous catheter, PICC line and Hickman line insertion.

Education

Academic
journey.

DM · 2022–2024

Medical Oncology — with Distinction

AIIMS, New Delhi

Solid and hematological malignancies training

Stem cell transplant & CAR T cell therapy

Passed ESMO examination (Sep 2024)

MD · 2017–2020

General Medicine

JJM Medical College, Davangere (RGUHS, Bangalore)

State 1st Rank & Gold Medal (2020)

MBBS · 2011–2017

Bachelor of Medicine and Surgery

KMC, Mangalore (MAHE)

Dr. TMA Pai Gold Medal — Best Outgoing Student

Gold Medals: Microbiology, Pharmacology, Ophthalmology

Student Exchange — Maastricht University, Netherlands (2015)

Experience

Career
timeline.

Present

Assistant Professor, Medical Oncology

Father Muller Medical College, Mangalore — June 2025 onwards

2025

Project Scientist / Research Officer

AIIMS, New Delhi — Jan 2025 to May 2025

International Phase III trials — AVANZAR, EVOLVE

Multicentric oncology research & OPD/IPD care

2022–2024

DM Resident — Medical Oncology

AIIMS, New Delhi — India's Premier Cancer Training Centre

Awards & Achievements

Key highlights.

ESMO Travel Grant — Gynecological Cancer Congress

Vienna, Austria · June 2025

2nd Prize — Oral Presentation

Systemic Therapy in Malignant Pleural Mesothelioma · NALCCON 2024

2nd Prize — Poster Presentation

Chemotherapy Outcomes in Advanced Thymoma · NALCCON 2024

Poster Presentation — International Conference

Advanced Thymoma Treatment Outcomes · ACLC 2024, Hong Kong

Student Exchange — Maastricht University

Netherlands · 2015, during MBBS at KMC Mangalore

ESMO Examination — Certified

European Society for Medical Oncology · September 2024

Research & Publications

Research and
publications.

Latest Publication

ecancermedicalscience · 2025

Exploring the Enigma Within: A Retrospective Study of Primary Cardiac Sarcomas from a Tertiary Care Centre

A retrospective study examining primary cardiac sarcomas — rare and aggressive malignancies — from a tertiary care oncology centre. Published in ecancermedicalscience (2025).

Read Publication →

2025

Frontiers in Oncology · 2025

Long-term endocrine outcomes and quality of life in paediatric and young chronic myeloid leukaemia patients on tyrosine kinase inhibitor therapy: a prospective study from India

Read

Cancer Research, Statistics, and Treatment · Letter to Editor

Interrupting endocrine therapy in hormone-positive early breast cancer

Read

Journal of Rare Diseases · 2023

Fibroadipose vascular anomaly successfully treated with sirolimus: experience in 3 children

Read

Journal of Education and Health Promotion

A cross-sectional study on awareness and perception about basic life support / CPR among undergraduate medical students from coastal South India

Read

International Journal of Biomedical Research

Immature platelet fraction (IPF) as an indicator of platelet recovery in dengue fever

Read

Journal of Medical Science and Clinical Research

Acute Onset Pellagra Secondary to Isoniazid Therapy

Read

Ongoing Research

Active
investigations.

Study 01

Single arm Phase II study of single agent Pemetrexed in Platinum Resistant/Refractory Epithelial Ovarian or Primary Peritoneal Cancer

Study 02

Clinical insights and survival outcomes of Malignant Pleural Mesothelioma: An experience from a tertiary care centre in India

Study 03

Clinicopathological profile and treatment outcomes of advanced/unresectable thymoma from a tertiary care centre in India

Study 04

Real-world experience with Gestational Trophoblastic Neoplasia: A single-center retrospective analysis

Study 05

Role of celecoxib in reducing cognitive impairment in patients receiving definitive chemoradiation for head and neck carcinoma: A phase II randomised placebo-controlled trial

Study 06

Real-world experience with Malignant Ovarian Germ Cell Tumors (MOGCTs): A single-center retrospective analysis

Study 07

Pregnancy outcomes with gestational trophoblastic neoplasia

Book a Consultation